次世代シーケンシングサービスの市場規模、シェア、動向分析レポート：サービスタイプ別、ワークフロー別、最終用途別、地域別、およびセグメント動向：2024年～2030年

次世代シーケンシングサービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、次世代シーケンシングサービスの世界市場規模は2030年までに244億8,000万米ドルに達する見込みです。

2024年から2030年までのCAGRは22.68%で拡大する見込みです。次世代シークエンシング（NGS）技術の開発は、再現性とコスト削減の面で遺伝子シークエンシングに革命をもたらしました。その結果、臨床ラボや病院での利用を促進するため、NGS技術にいくつかの進歩がイントロダクションされるようになった。この分野における現在の技術革新のほとんどは、seq-technologyの使い方を単純化し、より洗練されたものにすることを中心に展開されています。これらの要因により、さまざまなエンドユーザーでNGSサービスの利用が進んでいます。

次世代シーケンサーは過去5年間で研究から臨床利用へと進歩しました。約14カ国が大規模なゲノムシークエンシングプログラムを開始し、2025年までに約6,000万人がゲノム解析を受けると予想されています。従来の疾患検査サービスプロバイダーは、seqベースの遺伝子検査の増加傾向に伴い、ポートフォリオを拡大しています。例えば、ARUP Laboratoriesは2022年3月に新しいコロナウイルス検査のリリースを発表し、IDbyDNA, Inc.は別の企業と提携して新しいコロナウイルス検査、呼吸器疾患のNGS検査を導入し、医師が肺炎やその他の呼吸器疾患の患者を評価するのに役立てようとしています。

製薬・バイオテクノロジー業界ではハイスループット・シーケンスの動向が高まっており、ハイスループットseq-プラットフォームのスピードと利便性を向上させ、ワークフローを簡素化するための開発が求められています。その結果、各社はサンプルの増幅や精製、開始入力の簡素化を実現するソリューションの開発に注力しています。2022年3月、イルミナ社はTruSigh Oncology（TSO）Comprehensive（EU）のリリースを発表しました。これは、複数の腫瘍遺伝子と指標を評価し、患者のがん個人の分子プロファイルを特定する包括的診断薬です。この体外診断（IVD）キットは、欧州全域のがん患者のゲノムの決定に影響を与える助けとなるもので、世界デビューはまず欧州で行われます。

次世代シーケンシングサービス市場レポートハイライト

• サービスタイプ別では、全ゲノムおよび全エクソームシーケンスの普及拡大により、ヒトゲノムシーケンスが2023年に最大の売上シェアを占めました。
• 遺伝子制御サービス、特にsmall RNAシーケンスとChIP-seqは予測期間中に有利なペースで成長すると予測されます。RNAシーケンスへの投資の増加が遺伝子制御サービスの成長に拍車をかけています。
• 他のワークフローステップと比較してシーケンスサービスの収益シェアが大きいのは、シーケンスプラットフォームの設置が増加しているためと考えられます。また、このステップのメンテナンスや回収コストが高いことも、収益増につながっています。
• 最終用途別では、がんの予後や診断へのNGS技術の応用が拡大していること、学術機関や大学が主要プロジェクトを立ち上げていることから、大学やその他の研究機関セグメントが2023年に最大の収益シェアを占めました。
• 北米は、同地域における技術の普及率が高く、技術を採用し疾患ターゲティングのための調査結果を導き出すための資金が利用可能であることから、2023年の市場を独占しました。
• GENEWIZ社やNovogene社などの企業は、主要NGS開発企業のプラットフォームに基づいてNGSサービスを提供しています。一方、イルミナやBGIといった企業は、シーケンス装置の開発や研究機関へのサービス提供を手掛けています。
• 2021年11月、ノボジーンは日本で開催された第44回日本分子生物学会（MSBJ）の年次総会で、日本の顧客向けに特別にシングルセルシーケンスサービスを開始すると述べた。
• GENEWIZの科学者たちは、プロジェクトのためのNGSソリューションの特定を支援しています。NeXT Dx TestはPersonalis, Inc.によって発売され、がん専門医ががん患者の新しい治療法や臨床試験の選択肢を特定するのに役立っています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場動向と展望
• 市場力学
  • シーケンス価格の下落
  • 女性とリプロダクティブ・ヘルスに関する意識の高まり
  • 臨床NGSの導入のために講じられた戦略
• 市場抑制要因分析
  • 大規模なNGS分析ワークフローの実装に関する課題
  • 単一細胞シーケンシングにおける分析上の課題
• 事業環境分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 サービスタイプビジネス分析

• 世界の次世代シーケンシングサービス市場：サービスタイプの変動分析
• ヒトゲノム解読サービス
• 単一細胞シーケンスサービス
• 微生物ゲノムベースのシーケンスサービス
• 遺伝子制御サービス
  • Small RNAシーケンスサービス
  • チップシーケンスサービス
  • その他の遺伝子制御ベースのサービス
• 動物および植物のシーケンスサービス
• その他のシーケンスサービス

第5章 ワークフロービジネス分析

• 世界の次世代シーケンシングサービス市場：ワークフロー変動分析
• プレシーケンスサービス
• シーケンスサービス
• データ分析サービス

第6章 最終用途ビジネス分析

• 世界の次世代シーケンシングサービス市場：最終用途の変動分析
• 大学およびその他の調査機関
• 病院とクリニック
• 製薬およびバイオテクノロジー企業
• その他

第7章 地域ビジネス分析

• 世界の次世代シーケンシングサービス市場地域別シェア、2022年および2030年
• 北米
  • 北米の次世代シーケンシングサービス市場、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 欧州次世代シーケンシングサービス市場、2018～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
  • スイス
• アジア太平洋地域
  • アジア太平洋地域の次世代シーケンシングサービス市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
  • シンガポール
• ラテンアメリカ
  • ラテンアメリカの次世代シーケンシングサービス市場、2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • MEA次世代シーケンシングサービス市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業の分類
• 戦略マッピング
• 企業市場/ポジショニングシェア分析、2023年
• 企業プロファイル・一覧表
  • Quest Diagnostics Incorporated
  • ARUP Laboratories
  • Applied Biological Materials, Inc.（abm）
  • Novogene Co, Ltd.
  • Azenta Life Sciences（GENEWIZ）
  • NanoString
  • Illumina, Inc.
  • PacBio
  • Veritas
  • BGI（Beijing Genomics Institute）
  • Gene by Gene Ltd.
  • Lucigen Corporation

List of Tables

• Table 1 List Of Secondary Sources
• Table 2 List Of Abbreviations
• Table 3 Global next generation sequencing services market by service type, 2018 - 2030 (USD Million)
• Table 4 Global next generation sequencing services market by workflow, 2018 - 2030 (USD Million)
• Table 5 Global next generation sequencing services market by end-use, 2018 - 2030 (USD Million)
• Table 6 North America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 7 North America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 8 North America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 9 North America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
• Table 10 U.S. next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 11 U.S. next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 12 U.S. next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 13 Canada next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 14 Canada next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 15 Canada next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 16 Europe next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 17 Europe next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 18 Europe next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 19 Europe next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
• Table 20 Germany next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 21 Germany next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 22 Germany next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 23 UK next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 24 UK next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 25 UK next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 26 France next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 27 France next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 28 France next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 29 Italy next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 30 Italy next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 31 Italy next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 32 Spain next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 33 Spain next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 34 Spain next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 35 Denmark next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 36 Denmark next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 37 Denmark next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 38 Sweden next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 39 Sweden next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 40 Sweden next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 41 Norway next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 42 Norway next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 43 Norway next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 44 Switzerland next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 45 Switzerland next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 46 Switzerland next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
• Table 51 Japan next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 52 Japan next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 53 Japan next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 54 China next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 55 China next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 56 China next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 57 India next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 58 India next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 59 India next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 60 Australia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 61 Australia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 62 Australia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 63 South Korea next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 64 South Korea next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 65 South Korea next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 66 Thailand next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 67 Thailand next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 68 Thailand next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 69 Singapore next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 70 Singapore next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 71 Singapore next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 72 Latin America next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 73 Latin America next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 74 Latin America next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 75 Latin America next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
• Table 76 Brazil next-generation sequencing services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 77 Brazil next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 78 Brazil next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 79 Mexico next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 80 Mexico next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 81 Mexico next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 82 Argentina next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 83 Argentina next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 84 Argentina next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 85 MEA next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 86 MEA next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 87 MEA next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 88 MEA next-generation sequencing services market estimates & forecasts, by country, 2018 - 2030 (USD Million)
• Table 89 South Africa next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 90 South Africa next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 91 South Africa next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 92 Saudi Arabia next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 93 Saudi Arabia next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 94 Saudi Arabia next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 95 UAE next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 96 UAE next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 97 UAE next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 98 Kuwait next-generation sequencing-based gene regulation services market estimates & forecasts, by service type, 2018 - 2030 (USD Million)
• Table 99 Kuwait next-generation sequencing services market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
• Table 100 Kuwait next-generation sequencing services market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
• Table 101 Participant's Overview
• Table 102 Financial Performance
• Table 103 Key Companies Undergoing Expansions
• Table 104 Key Companies Undergoing Acquisitions
• Table 105 Key Companies Undergoing Collaborations
• Table 106 Key Companies Launching New Products/Services
• Table 107 Key Companies Undergoing Partnerships
• Table 108 Key Companies Undertaking Other Strategies

List of Figures

• Fig. 1 Market Others process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary Others pattern
• Fig. 4 Market Others approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market summary, 2023 (USD Million)
• Fig. 9 Market segmentation & scope
• Fig. 10 Market driver impact
• Fig. 11 Market restraint impact
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Porter's analysis
• Fig. 14 SWOT analysis
• Fig. 15 Next-generation sequencing services market: Service type outlook and key takeaways
• Fig. 16 Next-generation sequencing services market: Service type movement analysis
• Fig. 17 Human genome sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Single-cell sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Microbial genome-based sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Gene regulation services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Small RNA sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Chip sequencing service market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Other gene regulation-based service market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Animal & plant sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Other sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Next-generation sequencing services market: Workflow outlook and key takeaways
• Fig. 27 Next generation sequencing services market: Workflow movement analysis
• Fig. 28 Pre sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Sequencing services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Data analysis service market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Next-generation sequencing services market: End-use outlook and key takeaways
• Fig. 32 Next-generation sequencing services market: End-use movement analysis
• Fig. 33 Universities & other research entities, 2018 - 2030 (USD Million)
• Fig. 34 Hospitals & clinics, 2018 - 2030 (USD Million)
• Fig. 35 Pharma & biotech entities, 2018 - 2030 (USD Million)
• Fig. 36 Other end-use, 2018 - 2030 (USD Million)
• Fig. 37 Global next generation sequencing services market: Regional outlook and key takeaways
• Fig. 38 North America next generation sequencing services market, 2018 - 2030 (USD million)
• Fig. 39 US key country dynamics
• Fig. 40 US next generation sequencing services market, 2018 - 2030 (USD million)
• Fig. 41 Canada key country dynamics
• Fig. 42 Canada next generation sequencing services market, 2018 - 2030 (USD million)
• Fig. 43 Europe next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 44 Germany key country dynamics
• Fig. 45 Germany next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 46 France key country dynamics
• Fig. 47 France next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 48 UK key country dynamics
• Fig. 49 UK next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 50 Italy key country dynamics
• Fig. 51 Italy next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 52 Spain key country dynamics
• Fig. 53 Spain next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 54 Denmark key country dynamics
• Fig. 55 Denmark next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 56 Sweden key country dynamics
• Fig. 57 Sweden next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 58 Norway key country dynamics
• Fig. 59 Norway next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 60 Switzerland key country dynamics
• Fig. 61 Switzerland next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 62 Asia-Pacific next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 63 China key country dynamics
• Fig. 64 China next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 65 India key country dynamics
• Fig. 66 India next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 67 South Korea key country dynamics
• Fig. 68 South Korea next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 69 Japan key country dynamics
• Fig. 70 Japan next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 71 Australia key country dynamics
• Fig. 72 Australia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 73 Thailand key country dynamics
• Fig. 74 Thailand next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 75 Singapore key country dynamics
• Fig. 76 Singopore next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 77 Latin America next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 78 Brazil key country dynamics
• Fig. 79 Brazil next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 80 Mexico key country dynamics
• Fig. 81 Mexico next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 82 Argentina key country dynamics
• Fig. 83 Argentina next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 84 MEA next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 85 South Africa key country dynamics
• Fig. 86 South Africa next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 87 Saudi Arabia key country dynamics
• Fig. 88 Saudi Arabia next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 89 UAE key country dynamics
• Fig. 90 UAE next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 91 Kuwait key country dynamics
• Fig. 92 Kuwait next generation sequencing services market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 93 Market participant categorization
• Fig. 94 Next generation sequencing services market share analysis, 2023
• Fig. 95 Strategy framework

Next-generation Sequencing Services Market Growth & Trends:

The global next-generation sequencing services market size is expected to reach USD 24.48 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.68% from 2024 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.

Next-generation sequencing has progressed from research to clinical use in the last five years. Around 14 nations have launched large-scale genome sequencing programs, with nearly 60 million people expected to have their genome analyzed by 2025. Conventional disease testing service providers have broadened their portfolio with a rising trend of seq-based genetic tests. For instance, ARUP Laboratories announced the release of new coronavirus tests in March 2022, and IDbyDNA, Inc. partnered with another firm to introduce new coronavirus tests, an NGS test for respiratory illnesses, to aid physicians in evaluating patients with pneumonia and some other respiratory problems.

With the rising trend of high throughput sequencing within the pharma and biotech industry, there is a need for more developments to improve the speed and convenience of high throughput seq-platforms and simplify workflows. As a result, companies are focusing on the development of solutions to simplify the amplification and purification of samples and starting input. In March 2022, Illumina, Inc. announced the release of TruSigh Oncology (TSO) Comprehensive (EU), a comprehensive diagnostic that evaluates several tumor genes and indicators to identify a patient's cancer's individual molecular profile. The in vitro diagnostic (IVD) kit would assist in influencing genomic decisions for patients with cancer across Europe, with its global debut taking place first in Europe.

Next-generation Sequencing Services Market Report Highlights:

• By service type, human genome sequencing held the largest revenue share in 2023 owing to greater penetration of whole genome and whole exome sequencing
• Gene regulation services, particularly small RNA sequencing and ChIP-seq, are anticipated to grow at a lucrative pace during the forecast period. Rising investment in RNA sequencing is fueling the growth of gene regulation services
• The larger revenue share of sequencing services as compared to other workflow steps can be attributed to an increase in the installation of sequencing platforms. High maintenance and recovery costs of this step have also resulted in greater revenue generation
• By end-use, the universities and other research entities segment held the largest revenue share in 2023 owing to the growing application of NGS technology for cancer prognosis as well as diagnosis and major projects taken up by academicians and universities
• North America dominated the market in 2023 owing to higher penetration of the technology in this region and the availability of funds to employ the technique and derive research findings for disease targeting
• Companies such as GENEWIZ and Novogene Corporation are engaged in offering NGS services based on platforms from major NGS developers. Companies such as Illumina and BGI, on the other hand, are involved in developing sequencing instruments and offering services to research entities
• In November 2021, Novogene stated during the 44th Annual Gathering of Molecular Biological Society of Japan (MSBJ) in Japan that they will be launching single-cell sequencing services specifically for their Japanese customers
• GENEWIZ scientists are assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for cancer patients

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Information analysis
  • 1.2.2. Market formulation & data visualization
  • 1.2.3. Data validation & publishing
• 1.3. Information Procurement
  • 1.3.1. Primary Others
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Market Model
• 1.7. Objectives
  • 1.7.1. Objective 1
  • 1.7.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Decline in sequencing prices
  • 3.3.2. Growing awareness pertaining to women & reproductive health
  • 3.3.3. Strategies undertaken for implementation of clinical NGS
• 3.4. Market Restraint Analysis
  • 3.4.1. Challenges pertaining to implementation of large-scale NGS analysis workflows
  • 3.4.2. Analytical challenges in single cell sequencing
• 3.5. Business Environment Analysis
  • 3.5.1. PESTEL Analysis
  • 3.5.2. Porter's Five Forces Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Type Business Analysis

• 4.1. Global Next Generation Sequencing Services Market: Service Type Movement Analysis
• 4.2. Human Genome Sequencing Services
  • 4.2.1. Human Genome Sequencing Services Market, 2018 - 2030 (USD Million)
• 4.3. Single-Cell Sequencing Services
  • 4.3.1. Single-Cell Sequencing Services Market, 2018 - 2030 (USD Million)
• 4.4. Microbial Genome-based Sequencing Services
  • 4.4.1. Microbial Genome-based Sequencing Services Market, 2018 - 2030 (USD Million)
• 4.5. Gene Regulation Services
  • 4.5.1. Gene Regulation Services Market, 2018 - 2030 (USD Million)
  • 4.5.2. Small RNA Sequencing Services
    • 4.5.2.1. Small RNA Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.5.3. Chip Sequencing Services
    • 4.5.3.1. Chip Sequencing Services Market, 2018 - 2030 (USD Million)
  • 4.5.4. Other Gene Regulation-based Service
    • 4.5.4.1. Other Gene Regulation-based Service Market, 2018 - 2030 (USD Million)
• 4.6. Animal & Plant Sequencing Services
  • 4.6.1. Animal & Plant Sequencing Services Market, 2018 - 2030 (USD Million)
• 4.7. Other Sequencing Services
  • 4.7.1. Other Sequencing Services Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

• 5.1. Global Next Generation Sequencing Services market: Workflow Movement Analysis
• 5.2. Pre Sequencing Service
  • 5.2.1. Pre Sequencing Service Market, 2018 - 2030 (USD Million)
• 5.3. Sequencing Service
  • 5.3.1. Sequencing Service Market, 2018 - 2030 (USD Million)
• 5.4. Data Analysis Service
  • 5.4.1. Data Analysis Service Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

• 6.1. Global Next Generation Sequencing Services Market: End-use Movement Analysis
• 6.2. Universities & Other Research Entities
  • 6.2.1. Universities & Other Research Entities Market, 2018 - 2030 (USD Million)
• 6.3. Hospitals & Clinics
  • 6.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 6.4. Pharma & Biotech Entities
  • 6.4.1. Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Global Next generation sequencing services market Share By Region, 2022 & 2030
• 7.2. North America
  • 7.2.1. North America Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. Target Disease Prevalence
    • 7.2.2.5. U.S. Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Target Disease Prevalence
    • 7.2.3.5. Canada Next generation sequencing services market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. Target Disease Prevalence
    • 7.3.2.5. Germany Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.3. UK
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Target Disease Prevalence
    • 7.3.3.5. UK Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Target Disease Prevalence
    • 7.3.4.5. France Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Target Disease Prevalence
    • 7.3.5.5. Italy Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Target Disease Prevalence
    • 7.3.6.5. Spain Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Competitive Scenario
    • 7.3.7.3. Regulatory Framework
    • 7.3.7.4. Target Disease Prevalence
    • 7.3.7.5. Denmark Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Target Disease Prevalence
    • 7.3.8.5. Sweden Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Target Disease Prevalence
    • 7.3.9.5. Norway Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.3.10. Switzerland
    • 7.3.10.1. Key Country Dynamics
    • 7.3.10.2. Competitive Scenario
    • 7.3.10.3. Regulatory Framework
    • 7.3.10.4. Target Disease Prevalence
    • 7.3.10.5. Switzerland Next generation sequencing services market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Target Disease Prevalence
    • 7.4.2.5. Japan Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Target Disease Prevalence
    • 7.4.3.5. China Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Target Disease Prevalence
    • 7.4.4.5. India Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Target Disease Prevalence
    • 7.4.5.5. South Korea Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Target Disease Prevalence
    • 7.4.6.5. Australia Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Target Disease Prevalence
    • 7.4.7.5. Thailand Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.4.8. Singapore
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Target Disease Prevalence
    • 7.4.8.5. Singapore Next generation sequencing services market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Target Disease Prevalence
    • 7.5.2.5. Brazil Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Target Disease Prevalence
    • 7.5.3.5. Mexico Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.5.4. Argentina
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Target Disease Prevalence
    • 7.5.4.5. Argentina Next generation sequencing services market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Target Disease Prevalence
    • 7.6.2.5. South Africa Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Target Disease Prevalence
    • 7.6.3.5. Saudi Arabia Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Target Disease Prevalence
    • 7.6.4.5. UAE Next generation sequencing services market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Target Disease Prevalence
    • 7.6.5.5. Kuwait Next generation sequencing services market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market/Position Share Analysis, 2023
• 8.4. Company Profiles/Listing
  • 8.4.1. Quest Diagnostics Incorporated
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. ARUP Laboratories
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Applied Biological Materials, Inc. (abm)
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Novogene Co, Ltd.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Azenta Life Sciences (GENEWIZ)
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. NanoString
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Illumina, Inc.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. PacBio
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Veritas
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. BGI (Beijing Genomics Institute)
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. Gene by Gene Ltd.
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives
  • 8.4.12. Lucigen Corporation
    • 8.4.12.1. Overview
    • 8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.4.12.3. Product Benchmarking
    • 8.4.12.4. Strategic Initiatives